Smith Shellnut Wilson’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $532K | Hold |
2,239
| – | – | 0.2% | 82 |
|
|
2026
Q1 | $473K | Sell |
2,239
-153
| -6% | -$32.9K | 0.21% | 78 |
|
|
2025
Q4 | $492K | Sell |
2,392
-257
| -10% | -$48.4K | 0.19% | 81 |
|
|
2025
Q3 | $416K | Sell |
2,649
-302
| -10% | -$46.6K | 0.16% | 88 |
|
|
2025
Q2 | $496K | Sell |
2,951
-1,448
| -33% | -$215K | 0.22% | 70 |
|
|
2025
Q1 | $606K | Buy |
4,399
+91
| +2% | +$11.6K | 0.28% | 62 |
|
|
2024
Q4 | $510K | Buy |
4,308
+168
| +4% | +$19.6K | 0.23% | 73 |
|
|
2024
Q3 | $458K | Hold |
4,140
| – | – | 0.21% | 77 |
|
|
2024
Q2 | $407K | Hold |
4,140
| – | – | 0.2% | 82 |
|
|
2024
Q1 | $463K | Hold |
4,140
| – | – | 0.25% | 73 |
|
|
2023
Q4 | $417K | Sell |
4,140
-53
| -1% | -$5.26K | 0.24% | 75 |
|
|
2023
Q3 | $364K | Hold |
4,193
| – | – | 0.22% | 77 |
|
|
2023
Q2 | $397K | Sell |
4,193
-51
| -1% | -$4.31K | 0.22% | 79 |
|
|
2023
Q1 | $320K | Hold |
4,244
| – | – | 0.19% | 90 |
|
|
2022
Q4 | $326K | Buy |
4,244
+7
| +0.2% | +$532 | 0.2% | 91 |
|
|
2022
Q3 | $283K | Buy |
4,237
+31
| +0.7% | +$1.97K | 0.19% | 95 |
|
|
2022
Q2 | $220K | Sell |
4,206
-371
| -8% | -$21.1K | 0.14% | 119 |
|
|
2022
Q1 | $260K | Buy |
4,577
+73
| +2% | +$3.91K | 0.14% | 122 |
|
|
2021
Q4 | $232K | Buy |
4,504
+83
| +2% | +$4.07K | 0.11% | 137 |
|
|
2021
Q3 | $219K | Buy |
4,421
+87
| +2% | +$4.72K | 0.13% | 133 |
|
|
2021
Q2 | $247K | Sell |
4,334
-218
| -5% | -$12.7K | 0.14% | 122 |
|
|
2021
Q1 | $277K | Sell |
4,552
-353
| -7% | -$19.5K | 0.17% | 107 |
|
|
2020
Q4 | $263K | Buy |
+4,905
| New | +$255K | 0.16% | 105 |
|
|
2020
Q1 | – | Sell |
-4,592
| Closed | -$232K | – | 127 |
|
|
2019
Q4 | $232K | Hold |
4,592
| – | – | 0.15% | 115 |
|
|
2019
Q3 | $217K | Buy |
+4,592
| New | +$210K | 0.16% | 116 |
|
|
2018
Q4 | – | Sell |
-3,757
| Closed | -$203K | – | 115 |
|
|
2018
Q3 | $203K | Buy |
+3,757
| New | +$192K | 0.18% | 116 |
|
|
2018
Q1 | $235K | Buy |
3,757
+190
| +5% | +$13K | 0.2% | 109 |
|
|
2017
Q4 | $219K | Buy |
3,567
+199
| +6% | +$12.3K | 0.19% | 118 |
|
|
2017
Q3 | $225K | Buy |
+3,368
| New | +$238K | 0.2% | 121 |
|
Other funds holding CAH
Smith Shellnut Wilson's CAH Position: Q2 2026 in Review
Smith Shellnut Wilson held its Cardinal Health (CAH) position steady in Q2 2026 at 2,239 shares worth $532K. The position accounts for 0.2% of the portfolio, ranked #82.
Smith Shellnut Wilson first reported a position in CAH in Q3 2017 and has held it in 29 quarters since. The position peaked at $606K in Q1 2025. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Smith Shellnut Wilson held 2,239 shares of Cardinal Health worth $532K as of Q2 2026.
- Smith Shellnut Wilson left its Cardinal Health share count unchanged in Q2 2026.
- Cardinal Health made up 0.2% of Smith Shellnut Wilson's portfolio in Q2 2026, its #82 holding.
- Smith Shellnut Wilson first reported a position in Cardinal Health in Q3 2017 and has held it in 29 quarters since.
- Smith Shellnut Wilson's Cardinal Health position peaked at $606K in Q1 2025.
- 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Smith Shellnut Wilson's 13F filing for Q2 2026, filed 3 Aug 2026.